Association between atopic eczema and cancer in England and Denmark

KE Mansfield, SAJ Schmidt, B Darvalics… - JAMA …, 2020 - jamanetwork.com
Importance Associations between atopic eczema and cancer are unclear, with competing
theories that increased immune surveillance decreases cancer risk and that immune …

[HTML][HTML] Lessons learned from the clinical presentation of common variable immunodeficiency disorders: a systematic review and meta-analysis

LMA Janssen, M van der Flier, E de Vries - Frontiers in immunology, 2021 - frontiersin.org
Background Diagnostic delay in common variable immunodeficiency disorders (CVID) is
considerable. There is no generally accepted symptom-recognition framework for its early …

Prevalence and characteristics of atopic dermatitis among young adult females and males—report from the Swedish population‐based study BAMSE

EK Johansson, A Bergström, I Kull… - Journal of the …, 2022 - Wiley Online Library
Background There is limited knowledge regarding prevalence and characteristics of atopic
dermatitis (AD) among young adults in the general population. Objectives To study AD …

Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures

A Egeberg, P Schwarz, T Harsløf… - JAMA …, 2021 - jamanetwork.com
Importance Systemic and inhaled corticosteroids negatively affect bone remodeling and
cause osteoporosis and bone fracture when given continuously or in high doses. However …

[HTML][HTML] Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults

A Barrett, J Hahn-Pedersen, N Kragh, E Evans… - The Patient-Patient …, 2019 - Springer
Patient-reported outcome measures (PROMs) provide an important complement to
physician-assessed clinical outcome measures in dermatologic diseases such as atopic …

Biological therapies for atopic dermatitis: a systematic review

S Zhou, F Qi, Y Gong, J Zhang, B Zhu - Dermatology, 2021 - karger.com
Background: Atopic dermatitis (AD) is a widely acquired, relapsing inflammatory skin
disease. Biologics are now widely used in patients with moderate-to-severe AD. Objective …

[HTML][HTML] Trends in atopic dermatitis—from standard pharmacotherapy to novel drug delivery systems

EB Souto, J Dias-Ferreira, J Oliveira… - International journal of …, 2019 - mdpi.com
Atopic dermatitis (AD) is a predominant and deteriorating chronic inflammation of the skin,
categorized by robust burning and eczematous lacerations in diverse portions of the body …

Advancements in extracellular matrix-based biomaterials and biofabrication of 3D organotypic skin models

SJ Phang, S Basak, HX Teh… - ACS biomaterials …, 2022 - ACS Publications
Over the last decades, three-dimensional (3D) organotypic skin models have received
enormous attention as alternative models to in vivo animal models and in vitro two …

The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada

M de Bruin‐Weller, A Gadkari, S Auziere… - Journal of the …, 2020 - Wiley Online Library
Background Cross‐sectional data on patient burden in adults with atopic dermatitis (AD)
from real‐world clinical practice are limited. Objective This study compared patient‐reported …

Unveiling the true costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe

M Augustin, L Misery, L von Kobyletzki… - Journal of the …, 2022 - Wiley Online Library
Atopic dermatitis (AD) is a chronic, auto‐immune condition that imposes a high burden on
individuals, society, and the healthcare system. Approximately 4.4% of adults and up to …